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ABSTRACT: More than 5% of any population suﬀers from
asthma, and there are indications that these individuals are
more sensitive to nanoparticle aerosols than the healthy
population. We used an air−liquid interface model of
inhalation exposure to investigate global transcriptomic
responses in reconstituted three-dimensional airway epi-
thelia of healthy and asthmatic subjects exposed to pristine
(nCuO) and carboxylated (nCuOCOOH) copper oxide
nanoparticle aerosols. A dose-dependent increase in
cytotoxicity (highest in asthmatic donor cells) and pro-
inﬂammatory signaling within 24 h conﬁrmed the reliability
and sensitivity of the system to detect acute inhalation
toxicity. Gene expression changes between nanoparticle-
exposed versus air-exposed cells were investigated. Hier-
archical clustering based on the expression proﬁles of all diﬀerentially expressed genes (DEGs), cell-death-associated
DEGs (567 genes), or a subset of 48 highly overlapping DEGs categorized all samples according to “exposure severity”,
wherein nanoparticle surface chemistry and asthma are incorporated into the dose−response axis. For example,
asthmatics exposed to low and medium dose nCuO clustered with healthy donor cells exposed to medium and high dose
nCuO, respectively. Of note, a set of genes with high relevance to mucociliary clearance were observed to distinctly
diﬀerentiate asthmatic and healthy donor cells. These genes also responded diﬀerently to nCuO and nCuOCOOH
nanoparticles. Additionally, because response to transition-metal nanoparticles was a highly enriched Gene Ontology term
(FDR 8 × 10−13) from the subset of 48 highly overlapping DEGs, these genes may represent biomarkers to a potentially
large variety of metal/metal oxide nanoparticles.
KEYWORDS: copper(II) oxide, nanoparticles, asthma, 3d human bronchial epithelial cells, air−liquid interface and transcriptomics
Asthma is a chronic respiratory disease with extremelyhigh susceptibility to environmental exposures such asallergens,1 chemicals,2 and particulate air pollutants.3−5
Asthmatic airways are typically chronically inﬂamed and
extremely hyper-reactive, with symptoms such as recurrent
wheezing, coughing, and shortness of breath. Asthma
prevalence has steadily increased over the last three decades
and is a major public health burden. The most recent survey
estimates that as much as 4.4% of the global population (334
million people) is aﬀected by asthma (Global Asthma
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Network, 2014). There is thus a clear need to prioritize
development of comprehensive risk assessment frameworks
and tools that take this highly susceptible population into
account during implementation of regulatory and monitoring
programs to curb or follow up on potentially hazardous
exposures.
The varied and conﬁgurable physical and chemical proper-
ties of ENM amplify their industrial and medical applicability.
Unfortunately, the toxicity of ENM can be mediated by
physical and chemical properties; including, but not limited to
size, shape, surface charge, aspect ratio, functionalization, etc.6,7
As a result, the number of toxicologically relevant nanoforms
scales dramatically. With regards to health hazard assessment,
this poses a tremendous burden (costs and ethical consid-
erations) on the extent of animal testing that will be required.
Eﬃcient, accurate and scalable ex vivo test methods which are
still applicable to human exposures and can be used to evaluate
the potential health hazards associated with ENM in a timely
manner, are needed. Three-dimensional cocultures for nano-
particle exposure at an air−liquid interface that mimics the
human lung have recently been developed.8,9 Using this system
in combination with adverse outcome assays, in vitro
simulation of particle exposure and potential health hazard
has been successfully performed for airborne particles and
ﬁbers.10−14
Metal oxides are one of the most abundantly produced types
of engineered nanomaterials (ENM) with production volumes
of up to thousands of tons every year. The electrical, optical,
and magnetic features of copper oxide (CuO) makes them
appealing for a variety of industrial and commercial
applications such as electronic chips, solar cells, lithium
batteries, paints, processed wood, and plastics. CuO nanoma-
terials have already been used or could be utilized in food
packaging,15 wound dressings,16 skin products, and hospital
textiles.17 Production volumes of CuO nanoparticles are
expected to reach 1600 tons by the year 2025.18 Therefore,
because CuO has a very high potential for both occupational
and consumer exposure, we have used it as a model to
investigate potentially enhanced nanoparticle sensitivity within
the context of pre-existing asthma. Unraveling the mechanistic
interplay between nanoscale materials and asthma has been
thus far limited to a handful of studies.19 As such, employing
an in vitro 3D human bronchial epithelial model in tandem
with extensive downstream transcriptomic assessment in
healthy and vulnerable individuals with a disease-compromised
respiratory system is the subject of this study. 3D human
bronchial epithelial cells cultured at an air−liquid interface that
mimics relevant inhalatory exposure20 were exposed to
aerosols of pristine (nCuO) and carboxylated (nCuOCOOH)
copper oxide nanoparticles. We hypothesized that coupling this
exposure setup with global transcriptomic assessment will
enable identiﬁcation of altered defense mechanisms and/or
enhanced particle sensitivity as a result of pre-existing asthma.
In addition, because these primary cells are derived from nasal/
bronchial biopsies of donors, mode-of-action based approaches
can inform on biomarker candidates that can be developed and
Figure 1. Experimental setup with exposure, nanoparticle, and donor cell characterization. (A) Schematic of aerosolization, dilution,
exposures, and implemented downstream bioassays. (B) Scanning electron microscope view of pristine (nCuO, upper panel) and COOH-
functionalized (nCuOCOOH, lower panel) copper oxide nanoparticles on a ﬁlter membrane. The ﬁlter pore sizes were 0.4 μm (nCuO) and 0.8
μm (nCuOCOOH). Twenty-four hours after the 1 h exposures at four diﬀerent doses, particle deposition could be visually observed in all non-
zero doses. Representative images of an air (zero) versus high dose in healthy and asthmatic donor cells are shown in (C). Cell layers of
donor cells are more homogeneous compared to asthmatic cells. Changes in cell cytotoxicity were assessed by measuring release of lactate
dehydrogenase (LDH) into culture medium (D). Twenty-four hours after exposures, a dose-dependent increase in relative LDH release,
consistent with increasing cytotoxicity, was observed for both nanomaterials and cell types (D). The y-axis represents percent cellular
cytotoxicity, with respect to their corresponding air-exposed controls. Maximum cell death observed across all exposures was around 25%.
Cytotoxicity was highest in asthmatic donor cells, and pristine nCuO appears to be more cytotoxic than COOH-functionalized nCuO
(nCuOCOOH). Bars are the mean with SD of three (healthy) or ﬁve (asthmatic) biological replicates. Each value was derived from the mean
of three technical replicates. Statistical signiﬁcance was inferred via two-way ANOVA and * denotes p-value < 0.05.
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investigated via noninvasive sampling in “high-exposure-risk”
and “high-susceptibility” subjects.
RESULTS AND DISCUSSION
Experimental Setup and Particle Dose Character-
ization. The experimental setup is depicted in Figure 1A. Cells
were exposed to nanoparticle aerosols for 1 h, and all assay
samples were collected after a 24 h incubation period. In a
single-exposure experiment, air control, low-, mid-, and high-
dose groups are exposed simultaneously using a Vitrocell
exposure system. Each Vitrocell consists of three slots
(inserts); thus, every time a test block is exposed, the cell
material within its three inserts originates from a single donor
only. Previous work has shown that when using this approach,
for any parameter, diﬀerences in the average for the donors are
not aﬀected by diﬀerences among sessions, test blocks, or
concentrations.20 Similarly, the diﬀerences in averages of the
four CuO concentrations are not aﬀected by interdonor
variation.
Aerosolization of nCuO resulted in agglomeration or
aggregation of the particles with a median mass aerodynamic
diameter (MMAD) of 1.8 μm (geometric SD = 1.57) and a
MMAD of 1.4 μm (geometric SD = 1.48) for nCuOCOOH,
measured using an aerodynamic particle sizer (APS) in the
high dose (buﬀer chamber). Agglomerates or aggregates are
likely to be the predominant form of the particle that
interacted with all types of cells in our experiments. Such
agglomeration or aggregation has been reported before.21,22
Particle concentration was calculated using an APS and a
scanning mobility particle sizer (SMPS) simultaneously. APS/
SMPS analyses showed particle concentrations of 6.15 × 105
and 1.65 × 106 particles/cm3 for nCuO and nCuOCOOH,
respectively. Scanning electron microscopy (SEM) images are
shown in Figure 1B. The actual exposure concentrations for
the low, mid, and high groups were deduced from parallel
exposures to be 23, 120, and 470 mg/m3, respectively, for
nCuO and 32, 128, and 495 mg/m3 for nCuOCOOH. The
deposited dose was determined for the low and mid groups to
be 14% (nCuO) and 15% (nCuOCOOH) of the actual exposure
concentrations. Because particle deposition at constant ﬂow
rates is governed by particle diameter,23 we can directly infer
that similar deposition rates (14−15%) will be observed in the
high group exposures. Aerosol deposition mechanisms in the
lungs, especially with relevance to drug delivery, have been well
studied. The deposition of an inhaled particle is dependent on
its size. Keeping in mind that the aerosolized nanoparticles
consisted of agglomerates with a mean diameter of 1.8 μm
(nCuOCOOH nanoparticles) and 1.4 μm (nCuO nanoparticles),
the observed 14−15% deposition rate is in line with modeled
and experimentally determined 10 to 20% human bronchial
airway deposition of unit density particles with a diameter of
1−2 μm.24,25
Real-Life Human Exposure Extrapolation. Extrapolat-
ing in vitro doses to human lungs is often problematic because
lung morphology, air ﬂow patterns and mucociliary particle
clearance are all subject to inter individual and physiological
state variability.26 Nonetheless, we have combined previous
calculations from similar exposure scenarios to derive estimates
of the equivalent human exposures for the low, mid and high
doses used herein. Regulatory occupational exposure limits do
not exist for CuO and its derived nanoparticles. Going by the
permissible exposure limit (PEL) (5 mg/m3) for respirable
dust of particles not otherwise regulated as deﬁned by the US
Occupational Safety & Health Administration (2012), the low,
mid and high dose exposures corresponded to approximately 1,
6, and 22 8 h work days of constant human conducting airways
exposure.
These real-life exposures were extrapolated as follows: ﬁrst
we averaged the two concentrations corresponding to low (23
and 32 mg/m3), mid (120 and 128 mg/m3), or high dose (470
and 495 mg/m3) for nCuO and nCuOCOOH particles. Having
used the same Vitrocell air−liquid interface exposure system,
we next derived mass/surface area exposure concentrations
from 27.5 mg/m3 (low), 124 mg/m3 (mid), and 482.5 mg/m3
(high) concentrations, as described for exposure of CeO2
nanoparticles.10 Following these calculations (summarized in
materials and methods section), at a ﬂow rate of 1.5 mL/min
and 15% deposition, donor cells in each Vitrocell insert were
exposed to approximately 1.2 μg/cm2 (low), 5.6 μg/cm2
(mid), and 21.7 μg/cm2 (high) nanoparticles. The average
deposited dose normalized by the regional surface area is the
default dose metric for respiratory eﬀects of inhaled poorly
soluble particles.27 As such, we extrapolated the mass/area
doses of the air−liquid interface to human bronchial
epithelium. Incidentally, for particles with average aerodynamic
diameters of 1−2 μm24 (note that the MMAD of aggregates/
agglomerates of nCuO and nCuOCOOH nanoparticles in the
current exposures are 1.8 and 1.4 μm, respectively), ﬁve
diﬀerent deposition models have assigned a bronchial
deposition rate of around 10%. Human bronchial airway
surface area of 2709−4767 cm2 for a healthy adult have been
reported.27,28 To avoid being too conservative in our human
equivalent dose estimates, we will use the 4767 cm2 bronchial
surface area to derive region-speciﬁc doses. Finally, in order to
relate the human equivalent dose to a real-life scenario, we
based our extrapolations on the 5 mg/m3 PEL of occupational
exposure (NIOSH, 2012). Shvedova and colleagues29
estimated the workplace nanoparticle human lung burden
per day as
×
×
= × × ×
× ×
=
(PEL) (ventilation during 8 h working day)
(deposition rate)
(5 mg/m ) (20 L/min 0.001 m /L 60 min/h
8 h/day)m /day (0.10)
4.8 mg/working day
3 3
3
=
= = μ
human equivalent dose
lung burden
target region surface area
4.8 mg
4767 cm
1.006 g/cm2
2
= −
human equivalent occupationally relevant exposure 
(workdays)
air liquid interface dose/area
human equivalent dose
This implies, the low (1.2 μg/cm2), mid (5.6 μg/cm2) and
high (21.7 μg/cm2) doses used in our study can be
extrapolated to 1.2 ÷ 1.006 = 1.2 days, 5.9 ÷ 1.006 = 5.8
days and 21.7 ÷ 1.006 = 21.6 days of constant exposure of the
bronchial airway to CuO and CuOCOOH nanoparticle aerosols
in an occupational setting. Therefore, all three doses employed
in the described air−liquid interface exposures can be
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described as human-relevant, from a realistic exposure
perspective.
Visual Microscopic Inspection and Cellular Cytotox-
icity Assessment. Microscopic examinations prior to nano-
particle exposure of the epithelia reveal vacuoles formed by
enlarged cells. Such structures could also be observed in the
epithelia constituted with cells from healthy donors, even
though to a lesser extent (Figure 1C, air exposure). These
vacuoles do not compromise the barrier function of the
epithelia, since the regularly measured transepithelial electrical
resistance of the epithelia derived from asthmatic donor cells
was within the normal range (>100 Ω*cm2). In addition, when
these asthmatic 3D cultures are established, culture media is
absent from the apical surface of the epithelia, further
conﬁrming the structural integrity of the epithelial surface
(information obtained via personal correspondence with
Epithelix). Nanoparticle exposure of cells resulted in visual
observable particle deposition at all doses, with the cells of
asthmatic origin showing a less homogeneous cell layer
compared to the cells from healthy donors (Figure 1C, high
dose exposure). In both the healthy and asthmatic cells, we
also observed cilia beating before and immediately after the
exposures. Twenty-four hours after the 1 h exposures, most of
the nanoparticle agglomerates/aggregates were located on the
outer side of the insert, possibly moved there by beating cilia.
LDH measurements showed that the cellular cytotoxicity was
less than 25% in all exposures (Figure 1D). Compared to
unexposed cells, a signiﬁcant (p-value < 0.05) increase in
cytotoxicity was observed in both healthy (high dose only) and
asthmatic cells (low, mid, and high dose), with the highest
levels of cytotoxicity detected in asthmatics. With impaired
tracheobronchial mucociliary clearance observed even in the
airways of nonsymptomatic asthmatic subjects,30 a higher
nanoparticle-induced cellular cytotoxicity in asthmatic donor
cells conﬁrms the reliability of the model to distinguish
asthmatic and healthy bronchial airways. Ineﬃcient particle
clearance prolongs epithelium−nanoparticle interaction, which
may lead to exacerbated particle-induced cytotoxicity from
dissolved Cu2+ ions or enhanced particle uptake. NCuO
induced greater cytotoxicity when compared to nCuOCOOH in
both healthy and asthmatic donor cells. Studies have shown
that cell-binding events and internalization of nanoparticles are
largely mediated by their surface chemistries (reviewed by Mu
et al.31). Phospholipids, containing negatively charged
phosphate groups, are the main components of pulmonary
surfactant and cell membranes. The relatively lower apoptotic
potential of the nCuOCOOH particles may be due (in part) to
the fact that in an aqueous environment such as the surface of
the respiratory epithelium deprotonation of the COOH
functional group yields anionic nCuOCOO‑ nanoparticles with
poor membrane binding eﬃciency (hence uptake). This line of
reasoning is consistent with studies showing enhanced
Figure 2. Cytokine proﬁling after nanoparticle exposures. Release of selected pro-inﬂammatory cytokines, previously associated with
exposure to CuO nanoparticles, including their agglomerates/aggregates, was carried out after exposures (A). Twenty-four hours after
exposures, a dose-dependent release of IL-6 and IL-8 was measured from cell culture medium. No clear dose-dependent pattern was
observed for MCP-1 release. Overall, the expression trend across doses for each nanoparticle was similar between protein (released
cytokines) and mRNA measured via microarray-based gene expression proﬁling (B). Statistical signiﬁcance was inferred using two-way
ANOVA. Transcript and protein levels of IL-6 and IL-8 progressively increase with dose, with the most signiﬁcant diﬀerences observed
between air-exposed and high dose-exposed donor cells in both asthmatic and healthy donor cells. A signiﬁcant diﬀerence between asthmatic
and healthy donor cells was only observed for IL-6 and IL-8 mRNA levels in cells exposed to the highest concentrations of nCuO. Degree of
signiﬁcance is represented by an *, where *, **, ***, and **** indicate p values <0.05, <0.01, <0.001, and <0.0001, respectively.
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cytotoxicity of positively charged metal and metalloid nano-
particles relative to their neutral counterparts.32
Selected Pro-inﬂammatory Cytokines Are Elevated in
a Dose-Dependent Manner. Being more than just a barrier,
the airway epithelium synthesizes and releases potent
immunomodulators like chemokines, cytokines, growth factors,
and antimicrobial peptides in response to an external stimulant.
These responses typify an intact defense response character-
istic of human airway epithelia.33 Depending on the dose and
type of material, ENM exposures typically trigger inﬂamma-
tion, marked by elevated levels of pro-inﬂammatory cytokines.
Twenty-four hours after the nanoparticle exposures, we
investigated changes in IL-6, IL-8, and MCP-1 since induction
of these cytokines has been observed in bronchial epithelial cell
cultures exposed to CuO and other metal oxide nanoparticles
such as CeO2, TiO2, and ZnO.
34−38 IL-8 was the most elevated
of all three cytokines. Increased levels of IL-6 and IL-8 were
measured in three healthy and ﬁve asthmatic donor cells
(Suppl. Figure 1A). Release of IL-6 and IL-8 was dose
dependent, being most signiﬁcant (p-value < 0.0001) in donor
cells exposed to the highest dose of nCuO nanoparticles.
MCP-1 was found to be elevated (only in response to pristine
nCuO nanoparticles) in two out of three and two out of ﬁve
healthy and asthmatic donor cells, respectively (Suppl. Figure
1B). IL-6 is a pleiotropic cytokine with a wide range of
biological activities in immune regulation, hematopoiesis,
inﬂammation, and oncogenesis,39 while IL-8 and MCP-1 are
neutrophil- and monocyte/basophil-attracting chemokines,
respectively. Given that the maximum level of MCP-1
measured across all donor cells was 4- to 75-fold less than
that of IL-6 and IL-8 respectively, assay detection limits
coupled to technical variability might explain the observed
inconsistency in MCP-1 induction. No signiﬁcant diﬀerence in
IL-6 and IL-8 secretion was observed between healthy and
asthmatic donor cells (Figure 2A), even after normalizing
cytokine release to percentage cell viability (data not shown).
The expression trend of all three cytokines, as measured by
microarray analysis was similar to secreted protein abundance
(Figure 2B). Although macrophages are very often emphasized
to be the ﬁrst line of defense in pulmonary ENM-induced
responses,40 release of IL-8 suggests that in the bronchial areas
of the lungs, epithelial cells are the responsible cell type that
play a role in triggering innate immunity responses and
neutrophil inﬂux into the lung tissue to uptake/internalize
foreign particles. This is in line with the well-studied role of the
respiratory epithelium in cytokine-mediated innate defense
(reviewed in Whitsett and Alenghat41). In terms of the
nanomaterial type, nCuO appears to be more bioreactive than
nCuOCOOH, as the highest levels of all three pro-inﬂammatory
cytokines were observed after nCuO exposure (Figure 2A,B).
Figure 3. Transcriptomic proﬁling of asthmatics versus healthy when exposed to air, nCuO, or nCuOCOOH. The gene expression of asthmatics
was compared to that of healthy donor cells after exposure to control air and three doses of nanoparticle-derived aerosols. (A) The most
upregulated genes in asthma air/healthy air consists of genes that represent a highly signiﬁcant (FDR 1 × 10−22) functional enrichment of
extracellular matrix organization. (B) Venn comparisons of diﬀerentially expressed genes (DEGs) identiﬁed in asthma/healthy exposed to
air to the combined DEGs from asthma/healthy exposed to low-, mid-, and high-dose nCuO and low-, mid-, and high-dose nCuOCOOH reveal
there is very little overlap across identiﬁed DEGs. This suggests there is a strong interaction between nanoparticle exposure and asthmatic
phenotype. (C) K-means clustering of only the 164 DEGs between asthma and healthy exposed to air, across all exposures, separates air-
exposed asthmatics and air-exposed healthy cells to the most distant clusters. Clusters of healthy donor cells exposed to control air are
colored brown, and those for asthmatic donor cells exposed to control air are colored pink.
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Transcriptomic Proﬁling of Control and Asthmatic
Donor Bronchial Epithelia Identiﬁes Known Asthma-
Related Genes. Previous studies have reported similarities
between the mRNA expression proﬁles of epithelial cells
cultured at the air−liquid interface and that of tracheal and
bronchial brushings from human airways.42,43 To validate the
disease model in this study, we examined whether the relative
expression of known asthma-associated genes, for the
corresponding tissue type (bronchial epithelium), was
consistent with the published literature. We identiﬁed genes
related to asthma by microarray-based comparative tran-
scriptomics on total RNA isolated from asthmatic and healthy
donor cells that had only been exposed to control air. In
addition, potential disease-modulating eﬀects resulting from
particle exposure were also investigated by analysis of
diﬀerentially expressed genes (DEGs) in healthy versus
asthmatic bronchial epithelial donor cells exposed at the air−
liquid interface to CuO and CuOCOOH nanoparticle-derived
aerosols. The ENM doses were selected such that cytotoxicity
was less than 30% even with the highest dose. By this
approach, gene expression proﬁling identiﬁes early tran-
scriptomic responses (biomarkers) that reﬂect the bioreactivity
of CuO nanoparticles and not just genes that are related to
general cell death.
Pathway analysis of genes identiﬁed as upregulated genes in
asthmatic donor cells revealed a highly signiﬁcant (FDR 1 ×
10−22) enrichment of genes that are functionally involved in
extracellular matrix organization (Figure 3A). The most
upregulated of which are collagen (COL1AI, COL4A1,
COL4A2, COL5A2 and COL7A1), TNC (tenascin C, a
ﬁbronectin binding protein), cadherin (CDH2, CDH4 and
CDH11), MRC2 (mannose receptor C type 2), and MMP13
(Matrix Metallopeptidase13). The relative expression of these
genes is in line with the increased expression of extracellular
matrix proteins (ﬁbronectin, MMP9, and MMP12) observed
within the airway smooth muscle of asthma patients when
compared to nonasthmatic controls.44 Araujo and colleagues44
also observed that deposition of type-I and type-III collagens
correlated with the clinical severity of asthma. Asthma
heterogeneity is widely acknowledged, with allergic asthma,
mediated by allergen-speciﬁc T helper type 2 (TH2) cells, the
most common and most studied form of asthma.45 Being that
its hallmark mechanistic feature is the synthesis and release of
the TH2 cytokines, IL-4, IL-5, and IL-13,
46 it is no surprise that
their expression levels were close to background in the studied
airway epithelial cell models. However, we did detect
signiﬁcantly elevated expression of IL-33 and TSLP (known
inducers of TH2-type proinﬂammatory mediators) in asthmatic
donor cells (Suppl. Figure 2A). Similarly, elevated levels of IL-
33 or TSLP, coupled with a concomitant correlation to disease
severity, have been observed in bronchial biopsies and cultured
bronchial epithelial cells derived from asthmatic patients.47−49
In terms of morphological changes, mucus accumulation
(implicated in airway obstruction) is a prominent feature of
asthma. Mucus hypersecretion, marked by an increase in the
number of goblet cells and upregulation of mucin genes
(notably MUC5AC and MUC5AB), as well as altered mucus
clearance due to a decrease in the number of ciliated cells and/
or cilia viability, are thought to both contribute to mucus
accumulation in asthmatic airways. Incidentally, we identiﬁed
modest but signiﬁcant decrease in expression of FOXJ1
(marker of ciliated epithelial cells) and an increase in both
MUC5AC (marker of goblet cells) and MUC5B in asthmatic
donor cells (Suppl. Figure 2B). Several other mucin and
mucin-like genes, MUC1, MUCL1, MUC2, MUC4, and
MUC7, were also identiﬁed as signiﬁcantly upregulated in
MucilAir cells from asthmatic donors (Suppl. Figure 2C). A
hierarchical cluster consisting of these upregulated mucin
genes clearly separates asthmatic from control donor cells
(Suppl. Figure 2D).
To answer whether particle exposure modulates the
asthmatic genotype, we compared gene expression changes
between asthmatic and healthy donor cells exposed to air or
nanoparticle-derived aerosols. A Venn distribution of the
topmost DEGs (fold change cutoﬀ ≥1.5-fold and a
Benjamini−Hochberg FDR of at most 5%) between healthy
and asthmatic donor cells exposed to Air, nCuO, or
nCuOCOOH is shown in Figure 3B. K-means clustering of all
exposure groups, based only on the genes that were
diﬀerentially expressed between asthmatic and healthy donor
cells exposed to the control air stream, is depicted in Figure
3C. Within this dendrogram, the healthy and asthmatic groups
occupy clusters that are farthest from each other. Conversely, if
in addition to the genes that were diﬀerent between asthmatics
and healthy exposed to air those genes diﬀering between
asthmatic and healthy donor cells exposed to either nCuO or
nCuOCOOH nanoparticle aerosols are included prior to
hierarchical cluster generation, partitioning of the resulting
cluster dendrogram then becomes based on exposure dose,
with the asthmatic air and healthy air groups occupying closely
related clusters (Suppl. Figure 3A,B).
In summary, when comparing air-exposed healthy and
asthmatics, the main diﬀerence between all samples is driven
by disease-related genes, and when the exposure to nanoma-
terials is considered, the main diﬀerence between samples is
driven by the exposure dose. The top pathways enriched by the
genes that are diﬀerentially expressed between asthmatics and
healthy, when unexposed (air) or exposed to either nCuO or
nCuOCOOH, are shown in Suppl. Figure 3C. An alteration from
asthma-relevant pathways (extracellular matrix organization,
FDR 1 × 10−22; collagen metabolic process, FDR 1 × 10−17;
extracellular matrix part, FDR 3 × 10−16) to pathways
associated with adverse eﬀects of metal oxide nanomaterials
(DNA damage response, FDR 1 × 10−6 to 1 × 10−2; response
to metal ion, FDR 6 × 10−14 to 1 × 10−8; response to inorganic
substance, FDR 2 × 10−7) is observed. Taken together, this
indicates that in response to nanoparticle exposure, the eﬀects
of the disease (i.e., asthma) are overshadowed by the adverse
exposure outcomes at the doses tested. From a mechanistic
viewpoint, a notable limitation of the current study is that
Mucilair asthmatic donor cells are obtained based only on
symptomatic, as such given the limited number of asthmatic
donors (N = 5), it is impossible to investigate particle exposure
susceptibilities of diﬀerent asthma subtypes.
Expression Proﬁle of DEGs Incorporate Nanomaterial
Dose, Functionalization and Asthma into the Dose−
Response Axis. To characterize the gene expression proﬁles
that represent adverse exposure to both nCuO and nCuOCOOH
as a function of dose, functional group, and disease state, a
total of 12 contrast sets for identiﬁcation of DEGs were
speciﬁed. The number of DEGs identiﬁed in each of the
speciﬁed contrast sets (A−L) is shown in Suppl. Figure 4A. In
total, 6523 DEGs were observed across all comparisons. The
number of DEGs correlated with the dose (progressive
increase in the number of DEGs from low dose to high
dose). No obvious trend could be identiﬁed from the number
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of DEGs with respect to material type or disease state.
However, the total number of DEGs from contrasts reﬂecting
exposure to nanoparticles irrespective of disease state, or
disease state exposures irrespective of the particle type, was
similar for healthy and asthmatics, while an excess of 1627
DEGs was observed in nCuO relative to the nCuOCOOH
exposures (Suppl. Figure 4B). This supports our previously
mentioned observation that following exposure to CuO
nanomaterials the diﬀerence between healthy and asthmatic
cells is mainly driven by genes that are modulated in response
Figure 4. Global diﬀerential expressed genes and genes related to regulation of cell death diﬀerentiate exposures according to dose, material
type, and disease state. In total, 6523 diﬀerentially expressed genes (DEGs) were identiﬁed when exposed healthy [H] and asthmatic [A]
cells were compared to their corresponding air-exposure controls. These genes were then obtained from the normalized expression matrix
and used for principal component analysis (PCA). The top two components, explaining about 65% of the variance between exposures, are
shown in (A). Colored ovals with dashed lines depict the diﬀerent doses from air (zero) to high dose (A, left to right). Circular symbols
represent healthy donors and triangles represent asthmatic donors. It can be seen from PCA that asthmatic donor cells exposed to the
relatively lower dose are overrepresented in the regions where the low, mid and high doses overlap. This indicates interaction between
disease and nanoparticle exposure and is further highlighted by the fact that all of the genes that are diﬀerentially expressed between baseline
asthmatics and healthy donor cells were also diﬀerentially expressed in response to nanoparticle exposure (B). Approximately 9% (567
genes) of the DEGs between exposed and unexposed donor cells were identiﬁed by pathway enrichment analysis to represent GO biological
processes corresponding to positive and negative regulation of cell death. Venn distribution of these nanoparticle/air DEGs related to cell
death is shown in (C). K-means clustering, exclusively based on these cell death related genes, diﬀerentiates and groups the samples
according to dose, surface chemistry, and disease state (D). The primary distribution of samples across the various branches of the
dendrogram can be attributed to the nanoparticle deposited dose, wherein all high-dose exposures were grouped together in branch 1, air-
exposed controls in branch 2A, and mid dose in branch 2B (D). All low-dose exposures are closest to the air-exposed controls in branch 2A,
except nCuO-low dose (asthmatics), which clustered with the mid doses (branch 2B), and all mid doses clustered in branch 2A except
nCuO-mid (asthmatics), which clustered in branch 1 with the high doses.
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to the nanomaterial exposure (Suppl. Figure 3C). On this
basis, the main diﬀerence between asthmatic and healthy cells
in response to nCuO/nCuOCOOH is more likely to be as a
result of diﬀerences in sensitivity than being due to a diﬀerent
eﬀect of these materials on asthmatic airways. However, a
limitation of the current study protocol is that, in the absence
of transcriptomic data over multiple time points, we cannot
rule out the possibility that the enhanced sensitivity of the
asthmatic epithelium derives from delayed (and not
insuﬃcient) self-regulation upon nanoparticle-induced irrita-
tion of the airways.
In order to visualize possible trends in the data arising from
the expression proﬁle of genes that signiﬁcantly change in
response to CuO and CuOCOOH exposure, we performed a
principal component analysis (PCA) that was based exclusively
on the 6523 genes that were signiﬁcantly diﬀerentially
expressed between exposed cells and their corresponding air
controls. The top two principal components, explaining about
65% of the variation, are shown in Figure 4A. The diﬀerent
dose groups (air, low, mid and high) in the PCA plot are
highlighted with distinct colors and oval shapes (legend).
Interestingly there are regions of overlap between adjacent
doses (low/mid, mid/high) wherein asthmatic cells exposed to
nCuO from the lower dose are overrepresented. For example,
in the overlap between low and mid doses, low nCuO-
asthmatic cells cluster closer to the mid dose exposures than
the other three [(1) nCuO-healthy, (2) nCuOCOOH-healthy,
and (3) nCuOCOOH-asthmatic] low dose groups. The same
holds true for the mid/high intersection. This is an indication
that the presence of asthma enhances the sensitivity to the
adverse eﬀects of nCuO exposure, and this sensitivity is
diminished by functionalization to a COOH group
(nCuOCOOH). This observation is in line with cytotoxicity
measurements in healthy and asthmatic cells after nCuO and
nCuOCOOH exposures (Figure 1D). We also observed that the
genes which are diﬀerentially expressed between asthmatic and
healthy donor cells exposed to only to control air were
diﬀerentially expressed between nanoparticle-exposed and air-
exposed healthy and asthmatic donor cells (Figure 4B),
meaning that the genes which reﬂect the asthmatic genotype
in this cohort are also involved in the response to nanoparticle
exposure. This could explain why the asthma versus healthy
gene expression proﬁles were so diﬀerent for donor cells
exposed to either air or aggregates/agglomerates of nCuO or
nCuOCOOH nanoparticles (Figure 3A). It is possible that
asthmatics are more susceptible to nanoparticle exposure
because the expression of some of the genes required to mount
a (possibly protective) response to nanoparticle exposure is
skewed in asthmatics, resulting in a delayed onset of the
mechanisms required to protect against the adverse eﬀects
caused by these particles.
Expression of Genes Involved in Regulation of Cell
Death Correlates with Cellular Cytotoxicity Assay.
Because the dose−response diﬀerentiation was similar for
both the cytotoxicity assay and expression proﬁle of all DEGs,
we next investigated whether this distinction is consistent for a
subset of DEGs that represent changes in cell viability. To this
end, we performed gene ontology (GO) based biological
process enrichment analysis using all 6523 DEGs as input list.
We used this global approach as opposed to biological process
Figure 5. Scatter plot of genes related to organization of the cilia 186 diﬀerentially expressed genes were identiﬁed by pathway analysis to
represent biological functions corresponding to cilia organization/cilia assembly (A). Average relative expression for each of these genes
were obtained by Z-score normalization of their mRNA intensity values across all samples for the nCuO and nCuOCOOH exposures. Z-scores
were then averaged for air, low, mid, and high nanoparticle doses. A scatter plot of air-exposed healthy versus asthmatic donor cells is shown
in (B). As an example of a pre-existing distinction between healthy and asthmatic airways, MCIDAS and RAB3IP genes with potential
relevance in the functionality of asthmatic airways are highlighted. Following exposure to nCuO (C, upper panel) or nCuOCOOH (C, lower
panel) nanoparticles/nanoparticle agglomerates, a bigger change in expression (green lines) of cilia-related genes can be observed in healthy
when compared to asthmatic donor cells. Furthermore, the low-dose response was distinct in all exposures, except in asthmatics exposed to
nCuO (dashed red circles), wherein the low-dose response overlaps with the mid- and high-dose responses.
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enrichment analysis for each of the contrast sets depicted in
Suppl. Figure 4A because the expression proﬁle of the
combined DEGs correlated better with dose, functional
group, and disease state than the number of DEGs for every
contrast. The top ﬁve enriched nonredundant GO terms were
regulation of cell death (GO:0010941), cilium organization
Figure 6. Shared DEGs highlight core molecular signature of nanosized CuO exposure and integrates all four tested parameters into a dose−
response gradient. Comparing nanoparticle-exposed healthy or asthmatic donor cells to their corresponding air-exposed controls resulted in
a total of 12 contrast sets. Forty-eight diﬀerentially expressed genes were identiﬁed to be shared between 9 or more of these contrasts sets;
i.e., 33 genes were shared across 9 contrasts, 12 genes in 10 contrasts, and 3 genes in 11 contrasts. A hierarchical cluster (upper panel) based
on these reoccurring 48 diﬀerentially expressed genes separates all groups along a dose−response gradient, which takes into account the
material surface chemistry and tissue health status. Response to transition metal nanoparticle, attributed to a subset of ﬁve metallothionein 1
genes, was identiﬁed as a highly enriched (FDR 9 × 10−13) biological process within these 48 shared DEGs. Connections between gene
nodes represent physical, predicted, and genetic interactions as well as shared protein domains and pathways.
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(GO:0044782), response to cytokine (GO:0034097), cell
projection assembly (GO:0030031), cilium assembly
(GO:0060271), and cellular response to cytokine stimulus
(GO:0071345). Adverse exposure to CuO nanoparticles is
known to aﬀect cell viability via oxidative stress, prolonged
inﬂammation, and DNA damage.50 From the list of enriched
biological processes represented by these 6523 DEGs (Suppl.
Table 1), we selected two biological processes representing
speciﬁc eﬀects on cell death−positive (GO: 0060548−383
genes) and negative (GO:0010942−271 genes) regulation of
cell death (Figure 4C and highlighted in Suppl. Table 2). In
very much the same way as cell cytotoxicity measurements
(Figure 1D), hierarchical clustering based solely on the
expression of these regulation of cell death genes diﬀerentiates
the exposures by dose (Figure 4D). Here, the enhanced
sensitivity of asthmatic airways is evident as, asthmatic cells
exposed to low and mid dose nanoparticles cluster closest to
control cells exposed to mid- and high-dose nanoparticles,
respectively. The three most distinct clusters are depicted in
the dendrogram as 1, 2A, and 2B (Figure 4C). Cluster 1
consists of all high-dose exposures as well as mid-dose nCuO
(asthmatic), cluster 2B consists of the remaining mid-dose
exposures and low-dose nCuO (asthmatic). and cluster 2A
consists of the remaining low-dose exposures and unexposed
controls.
Changes in Genes Related to Cilium Functionality
Highlight the Lower Potency of COOH-Functionalized
CuO Nanoparticles and also Suggest Defective Muco-
ciliary Clearance May Be Responsible for Enhanced
Nanoparticle Sensitivity in Asthmatic Donor Cells.
Dysfunction of cilia organization is the second most enriched
pathway represented by genes that were diﬀerentially expressed
in response to nCuO/nCuOCOOH exposure (Suppl. Table 2).
Cilium assembly and cell projection assembly are also related
pathways that are highly enriched by combined DEGs between
nanoparticle-exposed and air-exposed donor cells (Figure 5A).
Similar to the human airway, the MucilAir epithelial lining is
covered by a mucus layer, which is produced by goblet cells
and moved by ciliary beating. As a ﬁrst line of defense, particles
trapped within the mucus layer are cleared by highly
coordinated ciliary beating, known as mucociliary clear-
ance.51,52 Because cilium assembly and organization are key
processes involved in mucociliary clearance, and ciliary
dysfunction is a feature of moderate to severe asthma,53 we
next sought to answer whether the observed enhanced CuO
nanoparticles sensitivity in asthmatics compared to healthy
subjects, could be related to intrinsic diﬀerences in ciliary
function. To compare the relative expression of genes related
to cilium organization between any two samples, the
expression of 186 DEGs representing cilium organization
(GO: 0044782) across all individual samples were Z-score
normalized, separately for each nanomaterial. This normal-
ization enables us to derive the expression of each gene relative
to the entire population. Z-scores of each gene are then
averaged over biological replicates. Scatter plots of the average
relative expression of these genes between healthy versus
asthmatic cells exposed to control air and between exposed
versus unexposed cells are shown in Figure 5B,C.
The ﬁrst observation made is that there is a positive
correlation (Pearson correlation coeﬃcient, R = 0.64) in cilia
organization genes between healthy/asthmatic cells exposed to
control air (Figure 6B). Interestingly, two genes that were
found to be very diﬀerent in average relative expression
between healthy and asthmatic donor cells, MCIDAS and
RAB3IP (Figure 5B), functionally reﬂect diﬀerences between
healthy and asthmatic phenotype. RAB3IP, low expressed in
asthmatic donor cells, may be of relevance in extracellular
matrix remodeling due to its role as a modulator of actin
organization (www.genecards.org). Meanwhile, MCIDAS,
which is highly upregulated in healthy donor cells, is required
for the generation of multiciliated cells in respiratory
epithelium. Patients with genetic deﬁciencies in MCIDAS
suﬀer from recurrent upper and lower respiratory tract
infections due to reduced generation of multiple motile
cilia.54 Second, we observe that, low dose exposure to either
nCuO and nCuOCOOH, triggers an upregulation in the
expression of cilia-related genes, except in nCuO-exposed
asthmatic donor cells (Figure 5C, red circles). Upon exposure
to mid and high dose nanoparticles, the initial upregulation is
closely followed by downregulation. Downregulation of cilia-
related genes was clearly distinct between mid and high dose in
nCuOCOOH-exposed cells. An overlap of the mid/high response
was observed in nCuO-exposed healthy donor cells while in
nCuO-exposed asthmatic donor cells, the low/mid/high
response overlap. Taken together, we propose that mucociliary
clearance is activated as an initial protective response via
upregulation of genes involved in cilia organization. However,
an excessive airway activation−that is tightly coupled to
nanomaterial potency (greater dose−response overlap in
nCuO relative to nCuO COOH) and asthma phenotype (greater
dose−response overlap in asthmatic cells relative to healthy
cells) triggers a negative feedback mechanism leading to
downregulation of cilia-related genes. The ﬁnal observation
made is that, the expression scatter of cilia-related genes is
greatest in exposed healthy donor cells (Figure 5C, green
lines). That is, the extent of variation in expression of cilia-
related genes following nanoparticle exposure is higher in
healthy cells. This suggests that mucociliary clearance may be
less eﬀective in asthmatic airways due to an overall lower net
change in expression (decreased plasticity) of the genes that
are required for cilia (re)assembly and/or (re)organization
(Figure 5C).
A Subset of Highly Overlapping DEGs Represents a
Core Signature Response to CuO Nanoparticles. For
each nanoparticle subtype, when DEGs for each dose are
combined, only 31% of the DEGs were common between
nCuO- and nCuOCOOH-exposed healthy donor cells. Forty-
four percent of the DEGs were common between asthmatic
donor cells exposed to nCuO or nCuOCOOH nanoparticle
aerosols. Based on their distinct gene expression proﬁles, these
diﬀerentially functionalized nanoparticles behave like two
diﬀerent metal nanoparticles. However, from a health hazard
diagnostic perspective, it is essential to have a minimum set of
DEGs that recapitulate organ-level sensitivity to disease. As
such, we next asked whether there is a subset of DEGs whose
expression proﬁles can distinguish the nanoparticle (sub)type,
exposure dose and enhanced airway sensitivity as a result of
asthma. For this purpose, we performed comprehensive Venn
comparisons across all 12 exposed/unexposed contrasts (i.e.,
without combining DEGs from multiple doses). Using DEGs
present in at least 75% of the exposed/unexposed comparisons
(that is, nine or more contrasts) as cut-oﬀ, a group of 48 genes
are identiﬁed (Figure 6). A cluster dendrogram of these genes,
aligns nanoparticle type and disease state along the dose−
response axis in a very similar manner to general transcriptome
proﬁles, cell death related genes and LDH assay. Response to
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transition metal nanoparticle (FDR of 8 × 10−13) was
identiﬁed as a highly enriched pathway in this gene subset.
This pathway was enriched by a subset of type 1 metal-
lothionein (MT1) genes, which are metal-binding proteins
long known to be involved in metal homeostasis and
detoxiﬁcation in plants and animals,55 and more recently
have been identiﬁed to be highly deregulated in response to
metal-based nanoparticles.56−58 These 48 genes are outlined in
Table 1.
CONCLUSION
Realistic human-relevant in vitro models, combined with
focused in silico approaches, have the potential to more
reliably connect nanomaterial properties of concern to their
health hazards. A more complete understanding of how
nanomaterials can inﬂuence disease at the cellular and
molecular level will enable the incorporation of important
population and exposure susceptibilities into models. Here, via
extensive comparative analysis of 3D human bronchial
epithelial model (MucilAir) exposed to air or CuO-based
aerosols, we show that existence of asthma enhances sensitivity
of the airways to nanoparticle aerosols, possibly as a combined
result of a hyperactive airway and ineﬃcient mucociliary
clearance mechanisms in asthmatics. The observed enhanced
susceptibility to nanoparticle aerosols is of added relevance
considering that asthmatic airway constriction could not even
be replicated in this air−liquid interface model. Our data
highlights the relevance of employing a generally applicable
air−liquid interface exposure system,20 in tandem with
extensive transcriptomic characterization for health hazard
assessment. By focusing on highly overlapping diﬀerentially
expressed genes, we have also presented a concise list of
candidate biomarkers to adverse nCuO exposure, which by
themselves were able to incorporate particle surface chemistry
and pre-existing asthma into the dose−response gradient. This
“core signature”, which may be a combination of genes that
represent tissue defense and detoxiﬁcation mechanisms and
those involved in progression of adverse exposure outcomes,
can be used for human biomonitoring and surveillance.
MATERIALS AND METHODS
Experimental Equipment. A schematic of the exposure setup is
shown in Figure 1. The equipment consists of an aerosol generator, an
air−liquid interface exposure system, and the MucilAir 3D human
bronchial epithelial model. See the work of Kooter et al.10 for a
comprehensive description of the equipment. Details speciﬁc to the
current experimental setup are previously described,10,20 with a few
modiﬁcations that are outlined below.
Experimental Design. The experimental assessment involved
exposures to clean, humidiﬁed air, low, middle, and high
concentrations of CuO and CuOCOOH. Cell material for the exposures
originated from ﬁve asthmatic and three healthy donors. The
exposures were split up as 1 h sessions, each consisting of a test
block containing three inserts. Parallel exposure sessions were carried
out to assess, cytotoxicity, cytokine release, and RNA isolation for
microarray-based transcriptomics. Each Vitrocell consists of three
slots (inserts); thus, every time a test block is exposed, the cell
material within its three inserts originates from a single donor only.
There were in total three healthy and ﬁve asthmatic donors, and the
cell material of each donor was tested once in each session, once in
each test block, and once at each CuO/CuOCOOH concentration.
Aerosol Generation. The test atmosphere was generated by
aerosolizing nano-CuO and nano-CuOCOOH, 10−20 nm primary
particle size (average primary particle size, nm ca. 15; BET, m2/g 55
± 5, provided by NANOSOLUTIONS consortium). An air control, a
low-concentration, a mid-concentration, and a high-concentration
ﬂow were realized simultaneously. The test atmosphere for the high-
dose group was extracted from the buﬀer chamber using a mass ﬂow
controller (Bronkhorst Hi Tec B.V.) connected to a vacuum source.
Table 1. List of Highly Overlapping Diﬀerentially Expressed
Genes from Nanoparticle-Exposed/Air-Exposed Contrasts
avg log2
diﬀerence gene symbol Entrez Gene name
5.00 MT1G metallothionein 1G
4.81 MT1H metallothionein 1H
4.80 IL6 interleukin 6
4.57 MT1M metallothionein 1M
3.83 HSPA6 heat shock protein family A (Hsp70) member
6
3.56 MT1F metallothionein 1F
3.47 C11orf96 chromosome 11 open reading frame 96
3.22 SNHG12 small nucleolar RNA host gene 12
2.85 MT1E metallothionein 1E
2.64 GADD45B growth arrest and DNA damage inducible beta
1.87 SNHG15 small nucleolar RNA host gene 15
1.81 IFRD1 interferon related developmental regulator 1
1.77 DDIT3 DNA damage inducible transcript 3
1.71 SNHG1 small nucleolar RNA host gene 1
1.67 ODC1 ornithine decarboxylase 1
1.63 KLF10 Kruppel like factor 10
1.62 ATF3 activating transcription factor 3
1.59 RGS2 regulator of G protein signaling 2
1.58 JUN Jun proto-oncogene, AP-1 transcription
factor subunit
1.50 SNAR-A3 small ILF3/NF90-associated RNA A3
1.49 FOSL1 FOS like 1, AP-1 transcription factor subunit
1.44 NOP16 NOP16 nucleolar protein
1.43 IER2 immediate early response 2
1.41 DDX21 DExD-box helicase 21
1.39 AGPAT9 glycerol-3-phosphate acyltransferase 3
1.24 USP36 ubiquitin speciﬁc peptidase 36
1.18 NOP56 NOP56 ribonucleoprotein
1.16 ZFP36 ZFP36 ring ﬁnger protein
1.13 SLC30A1 solute carrier family 30 member 1
1.09 IRS2 insulin receptor substrate 2
1.07 NOP58 NOP58 ribonucleoprotein
1.02 RRS1 ribosome biogenesis regulator homologue
1.01 ORAOV1 oral cancer overexpressed 1
1.01 WDR43 WD repeat domain 43
1.00 NOP2 NOP2 nucleolar protein
0.94 NIFK nucleolar protein interacting with the FHA
domain of MKI67
0.90 RPF2 ribosome production factor 2 homologue
0.90 PIM3 Pim-3 proto-oncogene, serine/threonine
kinase
0.90 WSB1 WD repeat and SOCS box containing 1
0.88 RBM3 RNA binding motif protein 3
0.88 DUSP1 dual speciﬁcity phosphatase 1
0.86 GNL3 G protein nucleolar 3
0.83 EIF3J eukaryotic translation initiation
factor 3 subunit J
0.82 MAK16 MAK16 homologue
−0.89 ANKRD9 ankyrin repeat domain 9
−1.01 LRRC20 leucine rich repeat containing 20
−1.14 PIP5KL1 phosphatidylinositol-4-phosphate 5
-kinase like 1
−1.43 HILPDA hypoxia inducible lipid droplet associated
existing biomarker application(s) (Ingenuity
Knowledgebase)
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The test atmospheres for the mid- and low-dose groups were diluted
using an AirVac eductor (AirVac Engineering Company). The
incubator temperature was set to 37 °C, and relative humidity was
controlled at 50% for each group with a Testo RH/T device (Testo
635; Testo GmbH & Co).
Real-Life Exposure Dose Extrapolation. The Vitrocell system
consists of a module that supports several inserts with adaptable well
sizes. Based on the current conﬁguration, the total area of an exposed
insert is 0.3 cm2, the dose/area is given as particle concentration in air
(mg/m3) × deposition rate × volume of air in chamber (dm3) ÷
insert surface area (cm2).10 The Vitrocell setup, aerosol ﬂow rates, and
exposure time are as previously described.10 Thus, for a 14−15%
nanoparticle deposition rate, the eﬀective dose per Vitrocell insert for
the low nCuOCOOH dose is 32 mg/m3 × 0.14 × 0.09 dm3 ÷ 0.3 cm2 =
1.344 μg/cm2 (0.09 dm3 = 0.09 × 10−3 m3). For the purpose of
simplicity, we provide real-life exposure estimates that are based on
the average of the low, mid, and high doses of nCuO and nCuOCOOH
nanoparticles combined. Due to the fact that this MucilAir air−liquid
interface model replicates the conducting airways, the objective of the
extrapolated dose is to mimic real-life exposure of human bronchial
airways. In this region of the respiratory airways the modeled and
measured deposition rate of aerosols having an aerodynamic diameter
of 1−2 μm is estimated to be about 14%. The measured MMAD of
aerosolized nCuOCOOH and nCuO particles in the buﬀer chamber
(high dose) was 1.8 μm (geometric SD = 1.57) and 1.4 μm
(geometric SD = 1.48), respectively. In the absence of comprehensive
real-life exposure measurements, we extrapolated the in vitro
exposures to a time-weighted permissible exposure limit in an
occupational setting (see the Results and Discussion).
MucilAir3D Human Bronchial Epithelial Model.MucilAir fully
diﬀerentiated bronchial epithelial models (Epithelix Saŕl, Geneva,
Switzerland), reconstituted from primary human cells of healthy or
asthmatic donors, were used for air−liquid exposure to CuO and
CuOCOOH. The cells were maintained on 24-well Transwell culture
supports at an air−liquid interface using MucilAir culture medium,
supplemented with 1% amphotericin and 0.5% gentamicin, in a
humidiﬁed incubator at 37 °C with 5% CO2. Prior to performing the
experiments, the MucilAir cells were stabilized in culture for at least 1
week, while the medium was refreshed every 2−3 days. The
basolateral culture medium was refreshed approximately 24 h before
exposure. The MucilAir cells were rinsed with saline solution (0.9%
NaCl, 1.25 mM CaCl2, and 10 mM HEPES buﬀer) approximately 24
h before and again just before exposure to ensure that each individual
model contained a mucus layer of comparable thickness. Right before
exposure, the insets were transferred to the exposure device. The
stainless-steel wells of the exposure device contained MucilAir culture
medium to feed the cell monolayer from the basal side during a 1 h
exposure. The duration of the exposure is based on our experience
with this model.10 Cells were stabilized for another 24 h with 0.7 mL
of MucilAir culture medium at the basal site in a humidiﬁed incubator
(ca. 37 °C, 5% CO2) after exposures. Cell cultures were visually
inspected under the microscope before and after exposures to
examine their status. The lower relative humidity of 50% during the
exposures compared to the in vivo situation is not aﬀecting the cell
model. Negative controls (nonexposed in the humidiﬁed incubator, >
90%RH) and air exposed controls show both similar (absence of)
cytotoxicity (ﬁgure1D), where particle exposed cells show a dose
response. Other studies by authors show that even exposure up to 6 h
is feasible using this setup.59,60
Cellular Eﬀects. LDH-based cytotoxicity assessment (LDH-assay
kit Roche, Mannheim, Germany), pro-inﬂammatory signaling (multi-
ple analyses of cytokine (MCP-1, IL-6 and IL-8) release - human
inﬂammation 20plex FlowCytomix Multiplex, Ebiosciences) and
microarray-based global transcriptome proﬁling, were performed on
MucilAir cells that had been cultured for 24 h post-nanoparticle
exposure. The above-mentioned cytokines were chosen because they
were previously identiﬁed as upregulated in vitro following exposure to
nanoparticles (CeO2,
10,37 CuO20) in our laboratory. Samples for
analysis were taken from the basolateral medium only. For direct
comparison with mRNA expression measured from microarray
analysis, cytokine levels were log2 transformed. Error bars are mean
and standard deviation of three to ﬁve replicates, unless otherwise
speciﬁed. Two-way ANOVA (adjusted for multiple comparisons with
Tukey’s test) were performed for identiﬁcation of statistically
signiﬁcant diﬀerences in cellular cytotoxicity or cytokine release.
DNA Microarrays. Total RNA was isolated from cell lysates with
RNeasy Plus Mini Kit according to manufacturer’s instructions
(Qiagen, GmbH, Hilden, Germany). Desalting of the samples was
required and thus, additional puriﬁcation was performed by ethanol
precipitation with 3 M sodium acetate (Thermo Fisher Scientiﬁc Inc.,
Wilmington, NC).61 Quantity and quality of the RNA samples were
assessed by NanoDrop and Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA), respectively. All samples passed the
quality threshold of RNA integrity number (RIN) > 8 and were
included in the DNA microarray analysis.
One hundred nanograms of each independent RNA sample was
used to synthesize cRNA with T7 RNA polymerase ampliﬁcation
method (Low Input Quick Amp Labeling Kit, Agilent Technologies).
cRNAs were labeled with Cy3 and Cy5 dyes (Agilent Technologies)
and thereafter puriﬁed by using RNeasy Mini spin columns (Qiagen,
GmbH, Hilden, Germany). three hundred nanograms of a Cy3-
labeled sample and a Cy5-labeled sample were combined (total 600
ng), fragmented, and hybridized to the Agilent 2-color 60-mer oligo
arrays for 17 h at 65 °C (Agilent SurePrint G3 Human Gene
Expression v3 GE 8 × 60K). The slides were washed and scanned
with Agilent Microarray Scanner G2505C (Agilent Technologies).
Raw intensity values were obtained with the Feature Extraction
software, version 11.0.1.1 (Agilent Technologies).
All microarray data associated with this publication have been
deposited in NCBI’s Gene Expression Omnibus database62 and are
accessible via GEO series accession number GSE127773 (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE127773).
Data Preprocessing and Diﬀerential Expression Analyses.
Processing of raw ﬁles and diﬀerential expression analysis were carried
out with eUTOPIA,63 a platform-independent graphical user interface
based on R, with comprehensive workﬂows for gene expression
analysis. After importing raw ﬁles, signal intensity and background
corrections were performed by quantile normalization. Batch eﬀects
due to dye and array were accounted for during diﬀerential expression
analysis by ﬁtting the expression of each gene to a linear model
(Limma64,65), with the exposures speciﬁed as the “variable of interest”.
A Benjamini−Hochberg FDR of at most 5% and abs log2 diﬀerence ≥
0.58 were the speciﬁed cut-oﬀs to consider a gene as signiﬁcantly
diﬀerent between any two contrasts.
Hierarchical Clustering. Hierarchical clustering was carried out
with Perseus.66 Clustering parameters used were as follows; Distance:
Euclidean, Linkage: Average and Cluster Preprocessing: K-means. To
improve the diﬀerentiation accuracy and relevance of the generated
clusters, hierarchical clustering analyses was always performed on a
speciﬁed set of diﬀerentially expressed genes. The data matrix for
cluster generation was quantile-normalized, and batch eﬀects due to
dye and array were adjusted with the ComBat67 algorithm
implemented in eUTOPIA.
Gene Set Functional Enrichment Analysis. Gene ontology
(release date 2018-04-04) based identiﬁcation of overrepresented
biological processes were carried out using PANTHER68 enrichment
analysis tool. Scoring of signiﬁcantly enriched biological pathways was
done by multiplying the fold enrichment by the −log of the false
discovery rate. Biological processes with a < 1.5-fold enrichment and
FDR ≥ 0.001 were excluded. Alternatively, identiﬁcation and
visualization of biological networks from predicted enriched gene
functions were done using the web-based GeneMANIA prediction
server.69
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